Merck Millipore Mobius® Single-Use Magnetic Stirring System

Overview

The Merck Millipore Mobius® Single-Use Magnetic Stirring System is an engineered solution for aseptic, scalable mixing in biopharmaceutical manufacturing. It employs contactless magnetic suspension drive technology—eliminating mechanical shafts, seals, and lubricants—to deliver consistent, particle-free agitation across process scales from 10 L to 1000 L. Unlike conventional overhead or bottom-entry agitators, the Mobius® system operates via a rotating magnetic field generated by a reusable external motor platform, which couples with a permanently sealed, single-use impeller embedded in the base of a sterile, pre-validated polymeric mixing bag. This design ensures zero risk of seal leakage, particulate generation, or microbial ingress—critical attributes for drug substance and final formulation handling under cGMP conditions. The system is purpose-built for unit operations requiring high mixing efficiency at low liquid levels (e.g., buffer preparation, media blending, viral vector dilution, and final fill hold steps), and supports both upstream (cell culture harvest, clarification) and downstream (ultrafiltration/diafiltration hold, formulation buffer exchange) applications.

Key Features

• Contactless magnetic drive architecture eliminates rotating shafts, mechanical seals, and lubricants—ensuring zero particulate shedding and intrinsic compliance with USP and ISO 8573-1 Class 1 particulate requirements.
• Reusable motor platform and handheld controller enable rapid reconfiguration across multiple batch campaigns; only the single-use bag assembly requires replacement between uses.
• Low minimum working volume capability: as low as 2 L for the Mobius® MIX500 configuration, enabling efficient mixing during small-scale formulation development and clinical batch preparation.
• Minimal residual volume (<10 mL typical across all bag sizes) reduces product loss and simplifies transfer validation for high-value biologics.
• Modular scalability: identical control logic and operational workflow across 10 L, 50 L, 100 L, 200 L, 500 L, and 1000 L platforms—facilitating tech transfer and platform process standardization.
• Compact, mobile footprint with casters and integrated cable management—designed for flexible deployment in segregated cleanroom zones or multi-product facilities without fixed utility connections.

Sample Compatibility & Compliance

The Mobius® system is compatible with a broad range of biopharmaceutical fluids—including monoclonal antibodies, recombinant proteins, viral vectors, plasmid DNA, and vaccine intermediates—across pH 3–11 and viscosity ranges up to 20 cP. All single-use bags are manufactured from USP Class VI-certified, gamma-sterilized multilayer films (e.g., EVOH/PE/PP laminates) with extractables and leachables profiles fully characterized per USP and ICH Q5A(R2). The system supports full regulatory documentation packages, including Design Qualification (DQ), Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) protocols aligned with FDA 21 CFR Part 11, EU Annex 11, and ISO 13485. Validation support includes pre-approved risk assessments (FMEA), bioburden and sterility test data, and compatibility reports for common cleaning agents and sanitants used in adjacent equipment.

Software & Data Management

The handheld controller provides intuitive, menu-driven operation with real-time display of speed (rpm), runtime, and fault diagnostics. While the base system operates without network connectivity, optional analog outputs (4–20 mA) and digital interfaces (RS-485 Modbus RTU) allow integration into facility SCADA or MES systems for electronic batch record (EBR) linkage. Audit trails are maintained locally on the controller’s non-volatile memory, supporting GLP/GMP traceability requirements. Data export (CSV format) enables post-run analysis of mixing parameters against predefined acceptance criteria—essential for continuous process verification (CPV) and quality-by-design (QbD) initiatives.

Applications

• Final formulation mixing and hold steps prior to aseptic filling—especially for shear-sensitive modalities such as mRNA-LNPs and exosomes.
• Buffer and media preparation in segregated cleanroom suites, minimizing cross-contamination risk between products.
• Harvest hold tanks and intermediate purification step buffers in continuous and hybrid bioprocessing workflows.
• Clinical manufacturing support: rapid setup for small-volume batches (≤5 L) with full traceability and minimal qualification burden.
• Process development labs: scalable mixing data generated at 10 L directly informs 1000 L commercial process design space.

FAQ

Is the Mobius® system compliant with FDA 21 CFR Part 11 for electronic records and signatures?
Yes—the handheld controller supports user-level access control, electronic audit trails, and secure data export; when integrated with validated EBR systems, it meets Part 11 requirements for signature equivalence and record retention.
Can the same motor platform be used interchangeably across different bag sizes?
Yes—each reusable platform is rated for a defined volume range (e.g., MIX200 supports 100–200 L bags); however, platform-to-bag pairing must follow Merck’s validated configuration matrix to ensure torque delivery and impeller stability.
What regulatory documentation is provided with each Mobius® system order?
Customers receive a complete validation support package including Certificate of Conformance, Sterilization Certificate (gamma dose report), Extractables Summary Report, Biocompatibility Data (ISO 10993), and a template IQ/OQ protocol aligned with ASTM E2500 and ISPE Baseline Guide Vol. 4.